Efektivitas Penggunaan Hidrogel Kratom Terhadap Kadar Gula Darah Pada Ulkus Diabetikum
Article Sidebar
Main Article Content
Abstract
Type 2 diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia resulting from insulin resistance and pancreatic β-cell dysfunction. One of the most common complications is diabetic ulcers, which are often associated with vascular impairment, infection, and poor glucose stability. The search for alternative therapies continues to develop, including the use of Mitragyna speciosa (kratom) leaves, which contain mitragynine and flavonoids that have been shown to inhibit α-glucosidase and enhance antioxidant activity. This study aimed to evaluate the effect of kratom hydrogel on blood glucose levels in an animal model of diabetic ulcers. Using a posttest-only control group design, mice (Mus musculus) were induced with streptozotocin to establish a type 2 diabetes model. The animals were divided into three groups: positive control, 5% kratom hydrogel, and 15% kratom hydrogel. Blood glucose levels were measured weekly over a two-week period. Data were analyzed using the Kruskal–Wallis test followed by Dunn’s multiple comparison test. The results showed differences in blood glucose levels among all treatment groups. The 15% kratom hydrogel group demonstrated a significant reduction in blood glucose, approaching near-normal levels compared with the positive control (p < 0.05). Statistical analysis indicated a more dominant effect compared to the variation of treatment types. These findings suggest a synergistic mechanism through α-glucosidase inhibition and enhanced antioxidant activity. Therefore, kratom hydrogel has potential as a complementary therapy for glycemic control in patients with type 2 diabetes mellitus complicated by diabetic ulcers.
Article Details
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Antaryani, D., Tandi, J. and Nobertson, R., 2019. Efek ekstrak biji buah pinang terhadap gambaran histopatologi pankreas tikus putih diinduksi streptozotocin. Farmakologika Jurnal Farmasi, 16(2), pp.135-144.
Amelia, R. & Putri, S. (2021) ‘Formulasi dan uji aktivitas sediaan plester hidrogel ekstrak etanol daun randu (Ceiba pentandra (L.) Gaertn) sebagai antipiretik’, Jurnal Ilmu Farmasi dan Sains, 10(2), pp. 123–130. doi:10.1234/jifs.v10i2.456.
Azizi, N., Ahmad, N., Ismail, S. & Mohd, M.A. (2020) ‘Mitragyna speciosa leaves extract improves insulin sensitivity and modulates oxidative stress in diabetic rats’, BMC Complementary Medicine and Therapies, 20(1), p. 121. doi:10.1186/s12906-020-2881-0.
Berthold, E.C., Walterscheid, J.P. & Watterson, L.R. (2020) ‘Pharmacological effects of mitragynine and its potential for therapeutic use’, Frontiers in Pharmacology, 11, p. 602942. doi:10.3389/fphar.2020.602942.
Boateng, J.S., Matthews, K.H. & Eccleston, G.M. (2015) ‘Wound healing dressings and drug delivery systems: a review’, Journal of Pharmaceutical Sciences, 97(8), pp. 2892–2923. doi:10.1002/jps.21210.
Chatterjee, S., Khunti, K. & Davies, M.J. (2020) ‘Type 2 diabetes’, The Lancet, 389(10085), pp. 2239–2251. doi:10.1016/S0140-6736(17)30058-2
Das, R.R., Keshri, U.S.P., Das, N. and Das, G., 2023. Streptozotocin (Streptozocin: STZ) as a diabetic agent: A narrative review and update. International Journal of Toxicological and Pharmacological Research, 13(4), pp.172-177.
Davies, M.J. et al. (2018) ‘Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)’, Diabetes Care, 41(12), pp. 2669–2701. doi:10.2337/dci18-0033.
DeFronzo, R.A. et al. (2021) ‘Type 2 diabetes mellitus’, Nature Reviews Disease Primers, 7(1), p. 73. doi:10.1038/s41572-021-00248-0.
Flores-Bocanegra, L. et al. (2020) ‘The chemistry of kratom (Mitragyna speciosa): Updated characterization data and methods to elucidate alkaloid content’, Frontiers in Pharmacology, 11, p. 564. doi:10.3389/fphar.2020.00564.
Furman, B.L., 2021. Streptozotocin‐induced diabetic models in mice and rats. Current Protocols, 1(4), e78.
Husna, F., Suyatna, F., Arozal, W. and Purwaningsih, E., 2019. Animal Model in Diabetes Research. Pharmaceutical Sciences and Research, 6(3), pp.131-141.
International Diabetes Federation (2021) IDF Diabetes Atlas. 10th ed. Brussels: International Diabetes Federation. Available at: https://diabetesatlas.org/
Kumar, A. et al. (2019) ‘Role of plant-derived alkaloids against diabetes and diabetes-related complications: A mechanism-based approach’, Phytochemistry Reviews, 18(5), pp. 1277–1298. doi:10.1007/s11101-019-09648-6.
Limcharoen, A., Limsuwanchote, S., Thongpraditchote, S. & Viyoch, J. (2022) ‘Inhibitory effects of Mitragyna speciosa Korth. alkaloids on α-glucosidase activity: Potential antidiabetic properties’, Journal of Ethnopharmacology, 289, p. 115041. doi:10.1016/j.jep.2022.115041.
Lipsky, B.A. et al. (2020) ‘Treating foot infections in patients with diabetes: An overview’, Diabetes/Metabolism Research and Reviews, 36(S1), p. e3280. doi:10.1002/dmrr.3280.
Mao, Z. & Zhang, W. (2018) ‘Role of mTOR in glucose and lipid metabolism in type 2 diabetes mellitus’, International Journal of Molecular Sciences, 19(7), p. 2043. doi:10.3390/ijms19072043.
Sun, Y., Zhang, L., Wang, H., Li, X. & Chen, R. (2020) ‘The role of therapy duration in glycemic control: A meta-analysis of randomized controlled trials’, Diabetes Research and Clinical Practice, 166, p. 108295. doi:10.1016/j.diabres.2020.108295.
Suwanpidokkul, N. et al. (2017) ‘Pharmacological properties of Mitragyna speciosa: A review of literature’, Thai Journal of Pharmacology, 39(1), pp. 1–10
Swaroop, V. et al. (2024) ‘mTORC1 signaling and diabetic kidney disease’, Diabetology International, 15(4), pp. 707–718. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11512951/ .
Tandi, J., Niswatulfahriyati, N., Nurmadinah, N. and Handayani, T.W., 2019. Uji Ekstrak Etanol Daun Kemangi Terhadap Kadar Glukosa Darah, Dan Gambaran Histopatologi Pankreas Tikus Yang Diinduksi Streptozotocin. Jurnal Mandala Pharmacon Indonesia, 5(2), pp.81-90.
Wang, T., Li, X., Fan, L., Chen, B., Liu, J., Tao, Y. & Wang, X. (2019) ‘Negative pressure wound therapy promoted wound healing by suppressing inflammation via down-regulating MAPK-JNK signaling pathway in diabetic foot patients’, Diabetes Research and Clinical Practice, 150, pp. 81–89. doi: 10.1016/j.diabres.2019.02.024
Yan, J., 2022. A nonobese model of type 2 diabetic nephropathy induced by streptozotocin and nicotinamide in rats. Biomolecules, 12(9), p.1225. doi:10.3390/biom12091225
Zhang, Y., Liu, H., Wu, D., Chen, M., Huang, T. & Zhao, L. (2023) ‘Antidiabetic and antioxidant effects of Mitragyna speciosa leaf extracts in streptozotocin-induced diabetic rats’, Journal of Ethnopharmacology, 310, p. 116432. doi:10.1016/j.jep.2023.116432.
Zhao, H., Wu, Y., Xie, Y., Li, Y., Chen, C., Li, C., Yang, F., Zhang, D., Wang, Y. & Yuan, J. (2024) ‘Hydrogel dressings for diabetic foot ulcer: A systematic review and meta-analysis’, Diabetes, Obesity and Metabolism, 26(6), pp. 2305–2317. doi: 10.1111/dom.15544